InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-05-06 00:00:00 ET · period of report 2022-04-14 · accession 0001209191-22-027649 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-05-06 2022-04-14+ CPIX Jones James Dir P - Purchase $2.61 +318 20.6K +2% +$830.30

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-20 P A 28 $2.74 20,477 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2 Common Common Stock 2022-04-29 P A 30 $2.44 20,683 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3 Common Common Stock 2022-04-28 P A 30 $2.51 20,653 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4 Common Common Stock 2022-04-27 P A 30 $2.41 20,623 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5 Common Common Stock 2022-04-26 P A 30 $2.53 20,593 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6 Common Common Stock 2022-04-14 P A 28 $2.71 20,393 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7 Common Common Stock 2022-04-18 P A 28 $2.63 20,421 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8 Common Common Stock 2022-04-19 P A 28 $2.69 20,449 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9 Common Common Stock 2022-04-21 P A 28 $2.75 20,505 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10 Common Common Stock 2022-04-22 P A 28 $2.73 20,533 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11 Common Common Stock 2022-04-25 P A 30 $2.62 20,563 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.